Frequency of guideline‐defined cow's milk allergy symptoms in infants: Secondary analysis of EAT trial data
Authors:
- Rosie VincentRVRosie Vincent
- Stephanie J. MacNeillSMStephanie J. MacNeill
- Tom MarrsTMTom Marrs
- Joanna CravenJCJoanna Craven
- Kirsty LoganKLKirsty Logan
- Carsten FlohrCFCarsten Flohr
- Gideon LackGLGideon Lack
- Suzana RadulovicSRSuzana Radulovic
- Michael R. PerkinMPMichael R. Perkin
- Matthew J. RiddMRMatthew J. Ridd
- 7 December 2021
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 52 (1) , 82-93
Abstract
Background: Non‐IgE‐mediated Cow's Milk Allergy (CMA) has a prevalence of less than 1% in children. Guidelines developed to help non‐specialists diagnose CMA may lead to misattribution of normal symptoms and contribute to overdiagnosis of CMA. We sought to establish the frequency of symptoms during infancy associated with non‐IgE‐mediated CMA, using the international Milk Allergy in Primary Care (iMAP) guideline as representative of CMA guidelines more generally.Method: Secondary analysis of the Enquiring About Tolerance (EAT) randomized controlled trial (ISRCTN 14254740; 1303 exclusively breastfed 3‐month‐old healthy infants). Key outcomes were ≥2 iMAP symptoms associated with ‘mild‐moderate’ and ‘severe’ non‐IgE‐mediated CMA.Results: Whilst breastfeeding and parental atopy rates were higher than the general population, participants were otherwise similar to the population of England and Wales. Two or more non‐IgE CMA symptoms were reported by 25% families for mild‐moderate and 1.4% for severe symptoms each month between ages 3 and 12 months, peaking at 38% with ≥2 mild‐moderate and 4.3% ≥2 severe symptoms at three months, when participants were not directly consuming cow's milk. 74% of participants reported ≥2 mild‐moderate symptoms and 9% ≥2 severe symptoms in at least one month during this period. At six months there was no evidence of difference in the proportion of children with ≥2 symptoms between those consuming (29.5% mild‐moderate, 1.8% severe) and not consuming cow's milk (35.3% mild‐moderate, 2.2% severe). Mean monthly reporting of ≥2 symptoms was also no different between those with (15.8% mild‐moderate, 1.1% severe) or without eczema at baseline (16.7% mild‐moderate, 1.3% severe).Conclusions: Guideline‐defined symptoms of non‐IgE‐mediated CMA are very common in infants. Guidelines may promote milk allergy overdiagnosis by labelling normal infant symptoms as possible milk allergy.Keywords
This publication has 21 references indexed in Scilit:
- Which infants with eczema are at risk of food allergy? Results from a population‐based cohortClinical & Experimental Allergy, 2014
- New insights into the epidemiology of childhood atopic dermatitisAllergy, 2013
- The prevalence of food allergy: A meta-analysisJournal of Allergy and Clinical Immunology, 2007
- Effect of an Amino Acid-based Milk—Neocate ® —on Gastro-Oesophageal Reflux in Infants Assessed by Combined Intraluminal Impedance/pHPediatric Asthma, Allergy & Immunology, 2006
- Which aspects of the farming lifestyle explain the inverse association with childhood allergy?Journal of Allergy and Clinical Immunology, 2006
- Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of lifeJournal of Allergy and Clinical Immunology, 2006
- Systematic review of the occurrence of infantile colic in the communityArchives of Disease in Childhood, 2001
- Prevalence of Symptoms of Gastroesophageal Reflux During InfancyArchives of Pediatrics & Adolescent Medicine, 1997
- Prevalence of Food Additive intoleranceHuman & Experimental Toxicology, 1994
- A population study of food intoleranceThe Lancet, 1994